Article Per Year (5 Year)
p-Index From 2020 - 2025
0.444
P-Index
This Author published in this journals
All Journal Jurnal Medik Veteriner Journal of Fisheries & Marine
Salleh, Annas
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Veterinary

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Dietary Chlorella vulgaris Improves Growth and Modulates Gut Microbiota in Giant Freshwater Prawn (Macrobrachium rosenbergii) Norazman, Ammar; Tahir, Nur Diyana Mohamad; Salleh, Annas; Nor, Norhariani Mohd; Azmai, Mohamad Noor Amal; Ikhsan, Natrah
Jurnal Medik Veteriner Vol. 8 No. 2 (2025): October
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jmv.vol8.iss2.2025.350-367

Abstract

The giant freshwater prawn (Macrobrachium rosenbergii) is a commercially vital species in global aquaculture due to its rapid growth and high market demand, and Chlorella vulgaris is a nutrient-rich microalga lauded for its potential as a sustainable feed supplement. In this preliminary study, the effects of C. vulgaris supplementation on the growth and gut microbiota of giant freshwater prawn was investigated. Prawns were randomly assigned to three groups and fed diets supplemented with C. vulgaris at 0 g/kg (control), 30 g/kg (T1), or 60 g/kg (T2) for 14 days. For growth performance analysis, body weight was measured in a randomly selected 10% of the population at the beginning, midpoint, and end of the experiment. For gut microbiota analysis, faecal samples were taken from M. rosenbergii and used for DNA extraction and amplification via PCR. The PCR product was sequenced using 16S rRNA sequencing on Illumina platform. Results showed significantly improved growth rates in the supplemented groups, with T2 (highest growth rate) having 55% higher weight gain compared to the controls. Gut microbiota analysis revealed increased diversity, with the alpha biodiversity indices showing higher indices in supplemented groups compared to the controls although non-significant (p = 0.196, 0.136, 0.532 and 0.304 for Ace Chao1, Shannon and Simpson respectively). Specifically, the T1 group (highest alpha biodiversity) exhibited the following increases compared to the control: Ace by 53.55%, Shannon by 61.16%, Chao1 by 55.94%, and Simpson by 55.90%. In β-biodiversity analysis, there were shifts in bacterial community composition, with a notable increase in beneficial bacteria such as Synechocystis spp. and decrease in potentially pathogenic ones such as Chitinibacter spp. in the supplemented groups. PICRUSt2 analysis predicted enhanced metabolic pathways related to vitamin synthesis and energy metabolism, suggesting improved gut health and nutrient utilization. Although some results lacked statistical significance due to the short study duration, the findings suggest that long-term C. vulgaris supplementation may yield more pronounced benefits in M. rosenbergii aquaculture, potentially improving growth performance.
Designing of a Novel Aerolysin-based Multiepitope Vaccine against Aeromonas hydrophila Isolated from Osphronemus goramy Using Reverse Vaccinology: an in Silico Approaches Rozi; Tyasningsih, Wiwiek; Rahmahani, Jola; Aksono, Eduardus Bimo; Yunus , Muchammad; Al-Arif, Mohammad Anam; Kuncorojati, Suryo; Kusdarwati, Rahayu; Sari, Putri Desi Wulan; Amal, Mohammad Noor Azmai; Salleh, Annas; Khanand, Nadeem; Suwarno
Jurnal Ilmiah Perikanan dan Kelautan Vol. 16 No. 2 (2024): JURNAL ILMIAH PERIKANAN DAN KELAUTAN
Publisher : Faculty of Fisheries and Marine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jipk.v16i2.62035

Abstract

Graphical Abstract Highlight Research The study aims to develop a multi-epitope vaccine (MEV) against A. hydrophila by targeting the aerolysin toxin, a key virulence factor responsible for infections in fish and humans. Computational methods identified and optimized B-cell and T-cell epitopes, focusing on their ability to trigger immune responses without causing toxicity or allergenicity. In silico simulations demonstrated that the MEV has a strong binding affinity to immune receptors like TLR-4, MHC-I, and MHC-II, indicating its potential to induce robust cellular and humoral immunity. Structural analysis of the MEV showed a stable 3D conformation, with most residues in favorable regions, ensuring stability during immune activation. The MEV could enhance disease control in aquaculture and reduce human infection risks, offering a promising solution to address antibiotic resistance and the absence of effective vaccines. Abstract Aeromonas hydrophila, gram-negative, is a major pathogen responsible for various diseases in mammals, reptiles, amphibia, and vertebrates, including fish and humans. Targeting the specific toxin aerolysin in A. hydrophila is crucial to address antibiotic resistance and the lack of adequate and protective vaccines against this intracellular pathogen. This study aimed to identify a multi-epitope vaccination (MEV) candidate targeting A. hydrophila aerolysin toxin to combat the disease effectively. Standard biochemical characterization methods and sequencing of the 16S rRNA, rpoB, and aerA genes identified the isolate AHSA1 as A. hydrophila. Subsequently, we identified B and T cell epitopes on the aerolysin protein and separately predicted MHC-I and MHC-II epitopes. The epitopes are then evaluated for toxicity, antigenicity, allergenicity, and solubility. The vaccine design integrated multi-epitope-based constructs, utilizing specialized linkers (GPGPG) and EAAAK linkers to connect epitope peptides with adjuvants in the cholera toxin B component, thereby enhancing immunogenicity. Ramachandran plots showed that 85.25% of the residues were located in the most favorable regions, which was followed by the generously allowed zone (1.30%), the additional allowed regions (10.80%), and the forbidden regions (2.65%), thus confirming the feasibility of the modeled vaccine design. Based on docking simulations, MEV had the highest binding and interaction energies with TLR-4, TLR-9, MHC-I, and MHC-II (-1081.4, -723.2, 866.2, -9043.3 kcal/mol). Based on computational modelling, we expect the Aerolysin MEV candidate design to activate diverse immune mechanisms, stimulate robust responses against A. hydrophila, and maintain safety. The significant solubility, absence of toxicity or allergic response, and minimal side effects in animal testing all contribute to the potential clinical utility of this vaccine candidate.  
Co-Authors Aksono HP., Eduardus Bimo Al arif, Mohammad Anam Amal, Mohammad Noor Azmai Azmai, Mohamad Noor Amal Ikhsan, Natrah Khanand, Nadeem Kuncorojati, Suryo Nor, Norhariani Mohd Norazman, Ammar Rahmahani, Jola Rozi Sari, Putri Desi Wulan Suwarno Tahir, Nur Diyana Mohamad Tyasningsih, Wiwiek Yunus , Muchammad